瘤排水淋巴结 - 在免疫检查点治疗期间的朋友或敌人?
Janusz von Renesse1, Mei-Chun Lin2, Ping-Chih Ho1
1Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Epalinges, Switzerland.
Trends in cancer
|May 10, 2025
概括
排泄瘤的淋巴结是免疫和转移的关键. 了解它们的作用有助于改善癌症治疗,通过保留免疫反应,同时消除瘤.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 手术瘤学手术瘤学
背景情况:
- 瘤排水淋巴结 (TDLNs) 对于启动抗瘤免疫反应至关重要.
- 此外,TDLN也是癌症转移的主要部位.
- 这种双重作用在癌症治疗中提出了一个挑战:在不损害抗瘤免疫力的情况下消除瘤.
研究的目的:
- 探索淋巴结 (LNs) 中瘤特异性免疫反应的启动.
- 了解LNS内的瘤诱导的免疫受损的微环境.
- 检查TDLNs在免疫治疗中的作用,并评估提高癌症治疗疗效的策略.
主要方法:
- 关于癌症中TDLN功能的当前文献的综述.
- 在LNS的瘤微环境中分析免疫反应.
- 检查针对TDLN的临床数据和治疗策略.
主要成果:
- 在LNs中存在瘤可以导致免疫抑制的微环境,阻碍有效的抗瘤免疫力.
- 在促进和抑制抗瘤免疫反应方面,TDLN起着复杂的作用.
- 修改手术程序和治疗序列显示出改善治疗结果的希望.
结论:
- 保持或调节TDLN功能对于有效的癌症免疫疗法至关重要.
- 优化手术和治疗策略可以通过利用TDLN生物学来提高癌症治疗的疗效.
- 对TDLN操纵的进一步研究是有必要的,以改善患者的生存率和减少转移.
相关概念视频
Tumor Immunotherapy
401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Cytotoxic T Cells-mediated Immune Response
731
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
731


